admin

A look at two more stocks for your aggressive growth stock radar screen. Synaptics: https://www.zacks.com/stock/quote/SYNA?cid=CS-YOUTUBE-FT-VID NeoPhotonics: https://www.zacks.com/stock/quote/NPTN?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
0 Comments
When the Bank of Japan (BOJ) announced a policy of negative interest rates in 2016 by charging interest on reserve deposits, yields on Japanese government debt fell precipitously. The yield on 10-year Japanese government bonds fell to a record negative 0.135%, below the BOJ’s negative 0.1% reserve deposit rate. With the BOJ purchasing government bonds at an unprecedented annual rate
0 Comments
Oil prices pushed past $70 for the first time in a month in late-day trading Thursday. The rally is breathing new life into the energy sector, which is up 2.5% at this writing. For the past quarter, energy stocks have been lagging the broader market, so shareholders are cheering the newfound strength. To celebrate the
0 Comments
Have you seen gene editing and sequencing stocks recently? Source: Connect world / Shutterstock.com Illumina (NASDAQ:ILMN) is up 20% over the past three months. Beam Therapeutics (NASDAQ:BEAM) is up 45%. Editas Medicine (NASDAQ:EDIT) is up 90%. Intellia Therapeutics (NASDAQ:NTLA) is up 150%. Folks, the Genomic Revolution is here. And while everyone can see those big
0 Comments
A leader in the online sports gambling industry, DraftKings (NASDAQ:DKNG) is expanding its presence across the States and is expected to benefit from the upcoming football season. The company is making well-timed moves to build new offerings and achieve growth. It has successfully partnered with some of the top sports companies to offer a unique experience
0 Comments
Since before Robinhood (NASDAQ:HOOD) stock went public a month ago, the phrase “Robinhood stock” has been part of the vocabulary. Source: dennizn / Shutterstock.com These are stocks beloved of small investors, who often trade on Robinhood’s app and exchange views on Reddit’s r/Wallstreetbets. But after looking at its June quarter earnings report and what has
0 Comments
It’s been a little more than three weeks since Zomedica (NYSEAMERICAN:ZOM) reported its Q2 results. Despite reasonably healthy sales, ZOM stock gained just 14% from Aug. 11 through the end of the month.  Source: Postmodern Studio / Shutterstock.com Another InvestorPlace columnist, Ian Bezek, recently argued that Zomedica needs to raise its revenues considerably before investors
0 Comments